Evidence map›Paper›PMID 42021732›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2026

Common Coronary Artery Disease Risk Variants in Endothelial Regulatory Elements Modulate Tetraspanin 14 Expression and Notch Signaling.

Vivian S Lee-Kim, Gavin R Schnitzler, Shi Fang, Neeka Mardani-Kamali, Xiangmeng Shawn Cai, Ran Cui, Aurelie E Barry, Miad Zandavi, Hyung-Jin Yoo, Shashi Kant and 5 more

Abstract read
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Vivian S Lee-KimBroad Institute of MIT and Harvard, Cambridge, MA (V.S.L.-K., G.R.S., S.F., R.C., M.Z., J.M.E., R.M.G.).ORCID 0000-0003-0578-7781
Gavin R SchnitzlerBroad Institute of MIT and Harvard, Cambridge, MA (V.S.L.-K., G.R.S., S.F., R.C., M.Z., J.M.E., R.M.G.).
Shi FangBroad Institute of MIT and Harvard, Cambridge, MA (V.S.L.-K., G.R.S., S.F., R.C., M.Z., J.M.E., R.M.G.).
Neeka Mardani-KamaliDivision of Cardiology and Center for Pulmonary and Vascular Biology, Department of Pediatrics, Heart Center, Children's Health (V.S.L.-K., N.M.-K.), University of Texas Southwestern Medical Center, Dallas.ORCID 0009-0005-0286-7462
Xiangmeng Shawn CaiDepartment of Genetics (X.S.C., J.M.E.), Stanford University School of Medicine, CA.ORCID 0000-0002-2466-4210
Ran CuiBroad Institute of MIT and Harvard, Cambridge, MA (V.S.L.-K., G.R.S., S.F., R.C., M.Z., J.M.E., R.M.G.).ORCID 0000-0002-3236-4082
Aurelie E BarryDivision of Cardiovascular Medicine and Division of Genetics, Department of Medicine (V.S.L.-K., G.R.S., S.F., A.E.B., H.-J.Y., R.M.G.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Miad ZandaviBroad Institute of MIT and Harvard, Cambridge, MA (V.S.L.-K., G.R.S., S.F., R.C., M.Z., J.M.E., R.M.G.).
Hyung-Jin YooDivision of Cardiovascular Medicine and Division of Genetics, Department of Medicine (V.S.L.-K., G.R.S., S.F., A.E.B., H.-J.Y., R.M.G.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.ORCID 0000-0001-5467-8341
Shashi KantDivision of Cardiovascular Medicine, Department of Medicine (S.K.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.ORCID 0000-0001-8772-6813
Ragini MahajanCenter for Theoretical Biological Physics (R.M., E.L.A.), Rice University, Houston, TX.ORCID 0000-0002-1038-0698
Suhas S P RaoDepartment of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston (S.S.P.R., E.L.A.).
Erez Lieberman AidenDepartment of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston (S.S.P.R., E.L.A.).ORCID 0000-0002-5754-1719
Jesse M EngreitzBroad Institute of MIT and Harvard, Cambridge, MA (V.S.L.-K., G.R.S., S.F., R.C., M.Z., J.M.E., R.M.G.).
Rajat M GuptaBroad Institute of MIT and Harvard, Cambridge, MA (V.S.L.-K., G.R.S., S.F., R.C., M.Z., J.M.E., R.M.G.).ORCID 0000-0001-9865-4106

Funding

Scientific Core: Perturb-seq library generation, sequencing, and data analysisP01HL180323 · NHLBI · STANFORD UNIVERSITY · PI THOMAS QUERTERMOUS · 2025 to 2026
$7.1M
Single-cell, multi-omic investigation of epicardial adipose and coronary endothelial dysfunction in type 1 diabetesU01DK142338 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI RAJAT M GUPTA, Amit Majithia · 2024 to 2026
$3.0M
A genetic approach to identify the common mechanisms of vascular diseaseDP2HL152423 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI GUPTA, RAJAT M · 2019 to 2022
$2.8M
High-throughput cellular genetics to connect noncoding variants to coronary artery disease genesR01HL164811 · NHLBI · BROAD INSTITUTE, INC. · PI JESSE M ENGREITZ, RAJAT M GUPTA · 2023 to 2026
$2.7M
Identifying the organotypic and disease-specific vascular cell populations by integrating single cell data with polygenic riskU01HL166060 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI GUPTA, RAJAT M, SEGRE, AYELLET VERED · 2022 to 2025
$2.2M
Tspan14 expression and function in cardiovascular diseaseR00HL163411 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI Vivian Lee-Kim · 2024 to 2026
$696k
Tspan14 expression and function in cardiovascular diseaseK99HL163411 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI LEE-KIM, VIVIAN · 2022 to 2023
$258k
Mixed Lineage Kinase 2 (MLK2) and vascular homeostasisR03TR004452 · NCATS · BRIGHAM AND WOMEN'S HOSPITAL · PI KANT, SHASHI · 2023 to 2023
$173k
NCATS NIH HHS R03 TR004452NHLBI NIH HHS DP2 HL152423NHLBI NIH HHS K99 HL163411NHLBI NIH HHS P01 HL180323NHLBI NIH HHS R00 HL163411NHLBI NIH HHS R01 HL164811NHLBI NIH HHS U01 HL166060NIDDK NIH HHS U01 DK142338
6 · The paper itself

Abstract

backgroundCoronary artery disease (CAD) is a complex condition and remains the leading cause of mortality worldwide. Genome-wide association studies have identified a CAD risk locus on chromosome 10q23 that is independent of traditional risk factors, providing an opportunity to uncover novel molecular mechanisms contributing to CAD pathogenesis.

methodsImproved fine-mapping approaches were used to prioritize noncoding variants at the 10q23 locus within the intronic region of

resultsFine-mapping identified 2 lead variants, rs17680741 and rs12260962, located within regulatory elements predicted to affect

conclusionsTogether, these data identify a regulatory element harboring CAD-associated variant at the 10q23 locus that modulates

Indexed as

Coronary Artery DiseaseEndothelial CellsPolymorphism, Single NucleotideReceptors, NotchTetraspaninsCells, CulturedGene Expression RegulationGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansPhenotypeSignal TransductionReceptors, NotchTetraspaninscoronary artery diseaseendothelial cellsgenetic variationgenome-wide association studyreceptor, Notch1tetraspanins

Identifiers

PMID42021732
PMCPMC13148780

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.